• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSB2000681 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products Supplementary Application 2020-12-30 丹麦诺和诺德公司 Novo Nordisk A/S In Review 2020-12-30 view
CYSB2101148 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products Supplementary Application 2021-08-12 Novo Nordisk (China) Pharmaceuticals Co Ltd view
JXSL1300026 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products Import Drug Application 2013-04-18 诺和诺德(中国)制药有限公司 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S Certificate Issued 2015-08-06 view
JYSZ2300050 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products License Renew 2023-12-05 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
JYSB1900351 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products Supplementary Application 2019-12-19 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2020-03-17 view
CXSL2200557 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products(3.3) New Drug Application 2022-11-04 Dongguan HEC Biopharmaceutical R&D Co Ltd;Sunshine Lake Pharma Co Ltd view
CXSS2300029 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products(3.3) New Drug Application 2023-05-07 Jilin Huisheng Biopharmaceutical Co Ltd view
JYSF1900005 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products Supplementary Application 2019-06-18 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2019-07-05 view
CYSB2101149 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products Supplementary Application 2021-08-12 Novo Nordisk (China) Pharmaceuticals Co Ltd view
JYSZ2300051 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products License Renew 2023-12-05 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
JYSB1900126 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products Supplementary Application 2019-06-19 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2019-07-05 view
JYSB2101181 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products Supplementary Application 2021-12-10 Novo Nordisk A/S view
CXSL2300300 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products(3.3) New Drug Application 2023-05-04 ChongQing Chenan Biopharmaceutical Co Ltd view
JXSS1800012 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products Import Drug Application 2018-05-07 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2019-05-28 view
JYSB2000138 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products Supplementary Application 2020-04-20 丹麦诺和诺德公司 Novo Nordisk A/S Filed 2020-04-23 view
CXSL2300687 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products(3.3) New Drug Application 2023-10-12 Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd view
JYSB1900125 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products Supplementary Application 2019-06-19 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2019-07-05 view
CXSL2100112 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products(3.3) New Drug Application 2021-04-02 吉林惠升生物制药有限公司 Jilin Huisheng Biopharmaceutical Co Ltd In Review 2021-04-01 view
CXSL2300301 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products(3.3) New Drug Application 2023-05-04 ChongQing Chenan Biopharmaceutical Co Ltd view
JXSS1800011 德谷门冬双胰岛素注射液 insulin degludec;Insulin Aspart Injection Biological Products Import Drug Application 2018-05-07 丹麦诺和诺德公司 Novo Nordisk A/S Certificate Issued 2019-05-28 view